Skip to main content
Mochida Pharmaceutical Co.,Ltd. logo

Mochida Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 4534 ISIN · JP3922800002 LEI · 3538008YGVRYRM8B7Q95 T Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2023-11-13 Interim / Quarterly Rep…
Country JP Japan
Listing T 4534

About Mochida Pharmaceutical Co.,Ltd.

https://www.mochida.co.jp/english/

Mochida Pharmaceutical Co., Ltd. is a research-driven company focused on the development, manufacturing, and sale of pharmaceuticals, healthcare products, and medical devices. The company's core pharmaceutical business concentrates on therapeutic areas such as cardiovascular diseases, with a key focus on circulatory agents. It is also active in other fields, including oncology, through partnerships for generic products. In its healthcare segment, Mochida develops and markets functional, low-irritating products based on dermatological science. Additionally, the company distributes medical instruments and equipment for diagnostic and surgical applications, contributing to a broad spectrum of medical care.

Recent filings

Filing Released Lang Actions
四半期報告書－第86期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau. It contains comprehensive financial statements, including the balance sheet, for the second quarter of the 86th fiscal period (ending September 30, 2023). It includes detailed management analysis, shareholding information, and auditor review information, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-13 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically confirming the accuracy of the contents of a Quarterly Report (Shihanki Hokokusho) for the first quarter of the 86th fiscal period. Since this is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into the specific categories like 10-K or IR, it falls under the general regulatory filing category.
2023-08-09 Japanese
四半期報告書－第86期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, covering the first quarter of the 86th fiscal period (April 1, 2023, to June 30, 2023). It contains detailed financial statements, including the consolidated balance sheet and income statement, and is prepared in accordance with the Financial Instruments and Exchange Act. This fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-09 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal certification by the CEO regarding the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). Since this is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like AGM or M&A, it is classified as a Regulatory Filing (RNS). FY 2023
2023-06-29 Japanese
内部統制報告書－第85期(2022/04/01－2023/03/31)
Governance Information Classification · 1% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the company's framework, scope, and assessment results regarding internal controls over financial reporting. This type of document is a standalone audit-related regulatory filing that does not fit into the categories of full annual reports (10-K) or earnings releases, but rather falls under the category of Audit Report / Information (AR) as it pertains to the assessment of internal control systems.
2023-06-29 Japanese
有価証券報告書－第85期(2022/04/01－2023/03/31)
Annual Report Classification · 1% confidence The document header explicitly identifies itself as an '有価証券報告書' (Yuuka Shouken Houkokusho), which is the Japanese equivalent of an Annual Report (10-K). It includes the fiscal year (第85期, 2022-04-01 to 2023-03-31), the company name (Mochida Pharmaceutical Co., Ltd.), and regulatory filing details under the Financial Instruments and Exchange Act. The content is a comprehensive annual financial disclosure. FY 2023
2023-06-29 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.